Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.62
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.32
Today|||52-Week Range
1.75
-13.25%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.62
Today’s open0.63
Day’s range0.62 - 0.67
Volume217,123
Average volume (3 months)373,278
Market cap$14.7M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
NDRAENDRA Life Sciences ...0.000.00%
XTNTXtant Medical Holdin...0.000.00%
GENEGenetic Technologies...0.000.00%
SNGXSoligenix Inc0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts